Ignite Creation Date:
2025-12-24 @ 1:17 PM
Ignite Modification Date:
2025-12-27 @ 4:15 PM
Study NCT ID:
NCT05148195
Status:
TERMINATED
Last Update Posted:
2024-03-13
First Post:
2021-11-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors
Sponsor:
Jiangsu Simcere Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-22
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-26
Completion Date Type:
ACTUAL
First Submit Date:
2021-11-15
First Submit QC Date:
None
Study First Post Date:
2021-12-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-10
Last Update Post Date:
2024-03-13
Last Update Post Date Type:
ACTUAL